Research & Development

TORONTO – AGE-WELL NCE Inc. (Aging Gracefully across Environments using Technology to Support Wellness, Engagement and Long Life) is pleased to announce funding for 22 new research projects that leverage technology to address the needs and challenges of older adults and their caregivers. Read More

MONTREAL – The McGill University Health Centre (MUHC) Foundation received a personal donation of $100,000 from Marc Parent (pictured), president and CEO of CAE, and MUHC Foundation board member. Read More

HALIFAX – Researchers at the QEII Health Sciences Centre in Halifax are working to expose the connection between the brain and COVID-19. By using the experimental Synaptive Evry MRI for imaging the heads of patients, the team can examine how COVID-19 may be affecting the brains of patients who are sickened by the disease. Read More

TORONTO – A study led by Toronto researchers will be the first in Canada to use blood-based antibody testing on a large, random sample of Canadians to better understand a critical question for policy makers: how long does immunity to COVID-19 last? Read More

HALIFAX – CO-VIC, the COVID-19 treatment and immunity study, will evaluate effectiveness of treatments for hospitalized patients suffering moderate to severe COVID-19 symptoms, while helping researchers discover more about immunity to the virus. Read More

TORONTO – Sunnybrook’s community of donors has come together to quickly raise over $1 million for a promising pan-Canadian COVID-19 clinical trial being coordinated by a Sunnybrook research team. Read More

TORONTO – A team at Sunnybrook is working to better understand how SARS-CoV-2, the virus that causes COVID-19, spreads in the environment. In their simulation study, a mannequin hooked up to a ventilator in a negative pressure room mimics a patient in an ICU room. Read More

LONDON, ON – Led by Lawson Health Research Institute, London Health Sciences Centre (LHSC), University Health Network (UHN) and General Dynamics Land Systems-Canada (GDLS-Canada), researchers have designed a non-invasive ventilation mask that could significantly reduce aerosolization – the production of airborne respiratory droplets that may contain viruses or bacteria – when treating patients with COVID-19. Read More

LONDON, ON – As part of a randomized controlled trial, a team from Lawson Health Research Institute is the first in the world to treat a patient with COVID-19 using a modified dialysis device. The device gently removes a patient’s blood, modifies white blood cells and returns them to fight hyperinflammation. It is being tested with critically ill patients at London Health Sciences Centre (LHSC). Read More

HALIFAX, NS – The Nova Scotia research community has come together to respond to the COVID-19 global pandemic with a collective investment of just over $1.5 million in COVID-19 focused research. The coalition announced that it will use the money to fund 40 different projects. Read More